Balasa Dinverno & Foltz’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$880K Buy
1,813
+114
+7% +$55.5K 0.06% 137
2022
Q2
$795K Buy
1,699
+48
+3% +$21.4K 0.05% 148
2022
Q1
$718K Sell
1,651
-159
-9% -$66.5K 0.05% 160
2021
Q4
$840K Buy
1,810
+19
+1% +$8.41K 0.05% 147
2021
Q3
$697K Sell
1,791
-240
-12% -$102K 0.05% 160
2021
Q2
$899K Buy
2,031
+246
+14% +$107K 0.06% 130
2021
Q1
$748K Sell
1,785
-334
-16% -$133K 0.06% 137
2020
Q4
$869K Buy
2,119
+203
+11% +$84.4K 0.07% 119
2020
Q3
$793K Buy
1,916
+314
+20% +$126K 0.08% 117
2020
Q2
$621K Buy
1,602
+258
+19% +$96.5K 0.07% 117
2020
Q1
$422K Buy
1,344
+127
+10% +$42.8K 0.05% 153
2019
Q4
$446K Buy
+1,217
New +$386K 0.05% 171
2019
Q1
Sell
-813
Closed -$233K 244
2018
Q4
$233K Buy
813
+8
+1% +$2.54K 0.03% 195
2018
Q3
$273K Buy
805
+8
+1% +$2.6K 0.03% 201
2018
Q2
$237K Buy
797
+29
+4% +$8.49K 0.03% 200
2018
Q1
$206K Buy
+768
New +$208K 0.03% 204
2017
Q4
Sell
-1,211
Closed -$295K 213
2017
Q3
$295K Buy
+1,211
New +$297K 0.05% 165

Other funds holding HUM

Balasa Dinverno & Foltz's HUM Position: Q3 2022 in Review

Balasa Dinverno & Foltz increased its Humana (HUM) stake by 6.7% in Q3 2022, buying an estimated $55.5K and bringing the position to 1,813 shares worth $880K. The position accounts for 0.06% of the portfolio, ranked #137.

Balasa Dinverno & Foltz first reported a position in HUM in Q3 2017 and has held it in 17 quarters since. The position peaked at $899K in Q2 2021. 1,000 funds tracked by Wall St. Rank hold HUM as of Q3 2022.

  • Balasa Dinverno & Foltz held 1,813 shares of Humana worth $880K as of Q3 2022.
  • Balasa Dinverno & Foltz bought 114 Humana shares in Q3 2022, an estimated $55.5K.
  • Humana made up 0.06% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #137 holding.
  • Balasa Dinverno & Foltz first reported a position in Humana in Q3 2017 and has held it in 17 quarters since.
  • Balasa Dinverno & Foltz's Humana position peaked at $899K in Q2 2021.
  • 1,000 funds tracked by Wall St. Rank held Humana as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.